Company Analysis

PolyPid Ltd. (PYPD)

Nasdaq: PYPD · Surgical & Medical Instruments & Apparatus · Petach Tikva, IL · filing with the SEC since 2014
Grade5.0
◀ Past 5.3● Present 4.0▶ Future 6.0
7 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Report filedFeb 25, 2026Feb 26, 2025Mar 6, 2024Mar 31, 2023Feb 28, 2022Mar 5, 2021··
Research and development23,80722,81116,14827,99030,55316,95414,08312,550
General and administrative7,1834,2735,5238,0109,6097,7043,5905,265
Operating income-32,967-28,029-22,867-38,888-43,145-26,272-18,560-18,364
Interest and investment income51744254826746847460126
Total non-operating income (expense)-685-951-929-540544-10,59711,65524,281
Income before income taxes-34,164-28,980-23,796-39,428-42,601···
Income tax expense54269129····
Net income including non-controlling interests···-39,557-42,601-36,869r-6,905r-5,917
Net income-34,169-29,022-23,865-39,557-42,601-36,869-6,9055,917
Net income to common shareholders···39,55742,60142,91613,327-89
Earnings per share, basic2.094.9116.9961.09r68.27r134.40b710.70b-4.80b
Earnings per share, diluted2.094.9116.9361.09r68.27r134.40b710.70b25.80b
Weighted average shares, basic16,351,8905,912,8901,404,368647,556r624,051r319,414b18,748b18,704b
Weighted average shares, diluted16,351,8905,912,8901,421,308647,556r624,051r319,414b18,748b20,445b
Weighted average shares, basic and diluted····624,051b319,414b18,748b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton PYPD · research, not advice